(1-((2S,3S,5R)-2-(Hydroxymethyl)-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3-yl)-1H-1,2,3-triazol-4-yl)methyl (2R,4aS,6aS,12bR,14aS,14bR)-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydropicene-2-carboxylate
Molbank · 06.11.2026 · 2026 (6) · M2255
DOI: 10.3390/m2255 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molbank, online erschienen am 06.11.2026. Verfasst von Pengzhen Zhu und 3 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Macau University of Science and Technology.
Abstract (Originalsprache)
A novel celastrol–AZT conjugate containing a 1,2,3-triazole linker was designed and synthesized through copper(I)-catalyzed azide–alkyne cycloaddition (CuAAC). A C29 propargyl ester of celastrol was first prepared and subsequently coupled with AZT to afford the target. The structure of 3 was characterized by 1H and 13C NMR spectroscopy, HSQC, COSY, DEPT-90, DEPT-135, FTIR, UV–Vis spectroscopy, and high-resolution mass spectrometry. The spectroscopic data supported retention of the celastrol core and successful formation of the triazole-linked nucleoside conjugate. In silico physicochemical and ADMET analyses suggested that introduction of the AZT moiety altered the lipophilic and permeability profile of the parent scaffold. The resulting conjugate expands the chemical space of C29-modified celastrol derivatives and provides a structurally characterized hybrid scaffold for further biological and physicochemical investigation.
Förderung
- Macau University of Science and Technology
Zitieren
APA
Zhu, P., Lam, W. K., Xie, Y., & Coghi, P. (2026). (1-((2S,3S,5R)-2-(Hydroxymethyl)-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3-yl)-1H-1,2,3-triazol-4-yl)methyl (2R,4aS,6aS,12bR,14aS,14bR)-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydropicene-2-carboxylate. Molbank, 2026(6), M2255. https://doi.org/10.3390/m2255
Vancouver
Zhu P, Lam WK, Xie Y, Coghi P. (1-((2S,3S,5R)-2-(Hydroxymethyl)-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3-yl)-1H-1,2,3-triazol-4-yl)methyl (2R,4aS,6aS,12bR,14aS,14bR)-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydropicene-2-carboxylate. Molbank. 2026;2026(6):M2255. doi:10.3390/m2255
BibTeX
@article{Zhu2026,
author = {Zhu, Pengzhen and Lam, Wai Kin and Xie, Yuhan and Coghi, Paolo},
title = {(1-((2S,3S,5R)-2-(Hydroxymethyl)-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3-yl)-1H-1,2,3-triazol-4-yl)methyl (2R,4aS,6aS,12bR,14aS,14bR)-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydropicene-2-carboxylate},
journal = {Molbank},
year = {2026},
volume = {2026},
number = {6},
pages = {M2255},
doi = {10.3390/m2255}
}
EUVIMED